Are any antibodies associated with primary hyperparathyroidism, and is hyperthyroidism an autoimmune disease?

Antibodies and Hyperparathyroidism/Hyperthyroidism

Primary hyperparathyroidism is typically NOT an autoimmune disease and has no routinely associated antibodies in clinical practice, while hyperthyroidism CAN be autoimmune when caused by Graves' disease, characterized by TSH receptor antibodies (TSHRAb).

Primary Hyperparathyroidism and Antibodies

The vast majority of primary hyperparathyroidism (PHPT) cases are caused by parathyroid adenomas or hyperplasia without an autoimmune mechanism 1, 2, 3. However, rare autoimmune cases have been documented:

Rare Autoimmune Forms

• Calcium-sensing receptor (CaSR) autoantibodies have been detected in approximately 6.7% of PHPT patients in research settings 4
• These antibodies can cause:
  • Acquired hypocalciuric hypercalcemia (AHH) with PTH-dependent hypercalcemia 5, 6
  • Lymphocytic parathyroiditis (extremely rare) 5
  • "Biased antibodies" that paradoxically enhance Gq signaling while suppressing Gi signaling 6

Clinical Reality

These antibody-mediated forms are exceptionally rare and NOT part of routine clinical evaluation. The 2025 French consensus on PHPT management makes no mention of antibody testing as part of standard diagnostic workup 1. Standard PHPT diagnosis relies on:

• Elevated serum calcium
• Inappropriately elevated or normal PTH
• Exclusion of secondary causes
• Imaging for surgical planning

Do not routinely test for anti-CaSR antibodies in PHPT patients. Consider this only in highly unusual presentations with fluctuating calcium levels, hypermagnesemia, and hypocalciuria 6.

Hyperthyroidism as an Autoimmune Disease

Yes, hyperthyroidism is frequently autoimmune—specifically when caused by Graves' disease, which is the most common cause of hyperthyroidism in iodine-sufficient areas 7.

Autoimmune Thyroid Disease Antibodies

The key antibodies in autoimmune thyroid disease include 7:

1. TSH receptor antibodies (TSHRAb)

   • Diagnostic for Graves' disease (hyperthyroidism)
   • Sensitivity and specificity approaching 100% 8
   • First-line test when Graves' disease is suspected 8

2. Anti-thyroid peroxidase antibodies (TPOAb)

   • Present in ~75% of autoimmune thyroid disease cases 7
   • More commonly associated with Hashimoto's thyroiditis (hypothyroidism)
   • Can be present in Graves' disease
   • Positive in 11.3% of disease-free population 7

3. Anti-thyroglobulin antibodies (TgAb)

   • Less specific than TPOAb
   • Positive in 10.4% of disease-free population 7

Clinical Algorithm for Hyperthyroidism

When evaluating suspected hyperthyroidism 9, 8:

Step 1: Confirm biochemical hyperthyroidism

• Low TSH with elevated free T4 (overt hyperthyroidism)
• If free T4 normal, check free T3 (T3 thyrotoxicosis)

Step 2: Determine etiology

• Typical presentation (young female, homogeneous goiter, ophthalmopathy): Diagnosis is clinical; no additional tests required for diagnosis, though TSHRAb confirms Graves' disease 8
• Atypical presentation: Measure TSHRAb first-line 8
• If TSHRAb negative, measure anti-TPO antibodies to assess for autoimmune thyroiditis 8

Key Distinctions

Autoimmune thyroid diseases are 5-10 times more common in women than men 7. The presence of thyroid autoantibodies:

• Identifies autoimmune etiology
• Predicts progression (e.g., TPOAb-positive subclinical hypothyroidism progresses to overt hypothyroidism at 4.3% per year vs. 2.6% without antibodies) 7, 10
• Increases with age 7

Important caveat: Not all hyperthyroidism is autoimmune. Other causes include toxic multinodular goiter, toxic adenoma, thyroiditis, and exogenous thyroid hormone—none of which involve autoantibodies 9, 8.